Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylethanolamine N-methyltransferase (PEMT) is an enzyme that catalyzes the methylation of phosphatidylethanolamine (PE) to form phosphatidylcholine (PC). It is primarily localized in the endoplasmic reticulum and mitochondria-associated membranes, especially in liver cells. PEMT plays a critical role in maintaining membrane integrity, regulating VLDL secretion, and contributing to choline homeostasis. Deficiency or dysregulation of PEMT can lead to various metabolic disturbances, including steatohepatitis and increased susceptibility to NAFLD. PEMT activity is regulated by substrate/product availability, hormonal factors, and genetic variants.
Inhibiting or modulating PEMT activity can alter PC/PE ratios, VLDL secretion, and choline metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylethanolamine N-methyltransferase (PEMT).